Quiz

1. NHS, 2019. Apixaban. [Online] Accessed via: Apixaban: a blood-thinning medicine to treat and prevent blood clots - NHS (www.nhs.uk) [21/11/21].

​

2. LaPelusa A, Dave HD. Physiology, Hemostasis [Online]. Nih.gov. StatPearls Publishing; 2021. Accessed via: https://www.ncbi.nlm.nih.gov/books/NBK545263/ [21/11/21]

​

3. Akanksha Agrawal, Kerndt CC, Biagio Manna. Apixaban [Online]. Nih.gov. StatPearls Publishing; 2021. Accessed via: https://www.ncbi.nlm.nih.gov/books/NBK507910/ [21/11/21]

​

4. Blogspot.com. 2021. Accessed via: https://1.bp.blogspot.com/-nXY3ECl8eW8/XRwyrth1CWI/AAAAAAAAANA/GMuqENyvXA09k1x-zdQtiY-VUIHDMNFVQCLcBGAs/s1600/Screenshot%2B2019-07-03%2Bat%2B12.43.00%2BPM.png [21/11/21]

​

5. Fazeel Z. Apixaban: An oral anticoagulant having unique mechanism of action with better safety and efficacy profile. MAMC Journal of Medical Sciences [Online]. 2016;2(2):63. Accessed via: https://www.mamcjms.in/article.asp?issn=2394-7438;year=2016;volume=2;issue=2;spage=63;epage=68;aulast=Fazeel [21/11/21]

​

6. NICE.org, 2021. Anticoagulation-oral: Scenario: Apixaban. Accessed via: https://cks.nice.org.uk/topics/anticoagulation-oral/management/apixaban/ [22/11/21]

​

7. Ronny Alcalai, Adi Butnaru, Gil Moravsky, Oren Yagel, Razek Rashad, Mahsati Ibrahimli, David Planer, Offer Amir, Gabby Elbaz-Greener, David Leibowitz. Apixaban vs. warfarin in patients with left ventricular thrombus: a prospective multicentre randomized clinical trial. European Heart Journal - Cardiovascular Pharmacotherapy; 2021. DOI: https://doi.org/10.1093/ehjcvp/pvab057 [22/11/21]

 

8. Louis Lau, Guo Cosmos, Terry Yip, Joyce Mak, Sunny Wong, Kelvin Lam, Grace Wong, Siew Ng, Francis Chan. Risks of post-colonoscopic polypectomy bleeding and thromboembolism with warfarin and direct oral anticoagulants: a population-based analysis. Thrombosis research; 2020, 185. p[135-141]. DOI: https://doi.org/10.1016/j.thromres.2019.11.010  [22/11/21]

​

9. Apixaban [Online]. Nih.gov. National Institute of Diabetes and Digestive and Kidney Diseases; 2018. Accessed via: https://www.ncbi.nlm.nih.gov/books/NBK548281/ [21/11/21]

 

10.Liakoni, E., Bravo, A.E.R., Krähenbühl, S. Hepatotoxicity of New Oral Anticoagulants (NOACs). Drug Saf. 2015. Vol 38, PP 711-720. Accessed via: https://link.springer.com/article/10.1007/s40264-015-0317-5#citeas [22/11/21]

​

11. PubChem, 2021. Annotation Record for Apixaban. National Center for Biotechnology Information. Accessed via: https://pubchem.ncbi.nlm.nih.gov/source/hsdb/8223 [22/11/21]

​

12. Clarke S-A, Alsaad AA, Mack A, Phillips MB. Apixaban-induced liver injury. BMJ Case Reports [Online]. 2016 Sep 20; bcr2016216744. Accessed via: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5030527/ [21/11/21]

​